Navigation Links
DIA Conference to Focus on Clinical Trial Disclosure and the Importance of Transparency
Date:9/10/2013

HORSHAM, Pa (PRWEB) September 10, 2013

The DIA conference Clinical Trial Disclosure: Towards a More Transparent World will provide guidance on potential implications of the transparency of clinical trial information in registration, reporting and more. The meeting, to be held Oct. 1 to 2 in Bethesda, Md., will bring together academics, government regulators and patient advocates to provide key guidance on:

  •     Requirements for clinical trial disclosure in the United States and the European Union
  •     The interaction among medical writing, regulatory affairs and clinical trial disclosure to maintain consistency for protocol registration and the reporting of results
  •     The impact of greater transparency in clinical trial disclosure on industry and academia
  •     The advantages and implications of the availability of clinical trial disclosure databases

“The continuing proliferation of national and industry-sponsored registries leaves many sponsors considering disclosure strategy, developing operational measures and looking for efficient ways to manage dissemination of clinical trial protocol information. We are excited to bring together these leaders to discuss moving the needle in clinical trial disclosures,” said Susan Cantrell, director of DIA North America.

Speakers include:

  •     Jarilyn Dupont, director of regulatory policy, Food and Drug Administration
  •     Mark Barnes, partner, Ropes & Gray LLP
  • <
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Elsevier organizes label-free technologies conference
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. Blending conference translates substance abuse research into practice
4. International conference to explore health of descendants of transatlantic slave trade
5. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
6. Nobel laureate to keynote international pharmaceutical conference at URI
7. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
8. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
9. AuntMinnie Begins Live Video Stream of ISCT Conference Proceedings
10. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
11. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 According to a new ... (III-V, II-VI, IV-IV, sapphire), Deposition Technology (CVD, MBE, ... Opto-electronic), Application, and Geography-2013-2020", published by MarketsandMarkets, the ... of 12.63% from 2014 to 2020 and reach ... data tables and 88 figures spread through 342 ...
(Date:7/28/2014)... July 28, 2014 The Healthcare ... graduates of its Advanced Training Program in Healthcare ... roles in their health care organization ranging from ... methodology of continuous quality improvement in the health ... Dr. Brent James’ internationally recognized Advanced Training Program ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
(Date:7/28/2014)... is proposing a new theory to explain why older ... necessarily show declines in the workplace or daily life. ... are to maintain focus on cognitive tasks. , "My ... we see in cognitive performance in different settings," says ... State and author of a paper describing the theory. ...
(Date:7/28/2014)... European project SOPHIE has evaluated the relationship between ... in health in Europe. The results show that ... Europe) and countries with contradictory policies (Eastern Europe), ... reported poorer health than men. Health inequalities are ... present a 27% higher risk of having poor ...
Breaking Medicine News(10 mins):Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Gender inequalities in health: A matter of policies 2
... Tenet Healthcare Corporation (NYSE: THC ) ... named to the company,s 2009 Circle of Excellence. ... of Excellence honors Tenet hospitals that have achieved ... performance. Key metrics used to evaluate the ...
... Life Well(SM)" Offers 10 Proven Tools to Combat Stress ... worries to family responsibilities, Americans are dealing with ever-increasing ... Mental Health America today launched an innovative public education ... stressful times. Called Live Your Life Well(SM) , ...
... Lung Cancer Alliance announced that a comprehensive ... high mortality rate was introduced with bipartisan support ... http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO )"We now ... approach to lung cancer in both Houses of ...
... Citizenship Priorities: Innovating for the Future, Enhancing Access, Safeguarding ... PARK, Ill., April 27 Abbott today announced the ... "Advancing Innovation." The report provides an update ... on the company,s mission to improve people,s lives around ...
... Argues That Best Opportunity to Maximize Shareholder Value Is ... 27 Anchor Capital, a stockholder of ... that it has sent a letter to the Board ... that BioScrip,s shareholder value would be maximized through simultaneous ...
... , The Ford Fusion Hybrid team has achieved ... gas, raising funds for the Juvenile Diabetes Research Foundation , , ... Passing the 1,000 mile mark at 9:08 a.m. this morning, the team will continue ... remaining , , , , ...
Cached Medicine News:Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 2Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 3Health News:New Campaign Helps Americans Deal With Stressful Times 2Health News:New Campaign Helps Americans Deal With Stressful Times 3Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 2Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 3Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 2Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 2Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 4Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 5Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 6Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 7Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 2Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 3
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/25/2014)... , July 25, 2014  Corporate libraries are constantly ... new advancements in technology and how to cope with ... in the pharmaceutical and medical device industries are increasingly ... information and services they provide. According ... there are many forces of change that leading corporate ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7Forces of Change Reshaping Corporate Libraries & Information Services 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... Based on the original MS-III ... electrosurgery certification, enhanced keypad ... ,The MiniStim® MS-IV peripheral ... for neuromuscular monitoring in operating ...
... is a super-light polypropylene mesh which offers ... is reduced considerably. Optilene Mesh LP is ... hernia repair procedures. It perfectly conforms,to anatomical ... Mesh LP adapts to the movements of ...
... a mesh plug to treat large or ... hernias and femoralhernias. The self-expanding plug perfectly ... completely. Premilene Mesh Self-Forming Plug is a ... Mesh. The plug corresponds with all properties ...
Medicine Products: